NCT06019065View on ClinicalTrials.gov

A SAD, MAD and Food Effect Study to Evaluate the Safety, Tolerability, PK, and PD of AJA001 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

March 26, 2024

Study Completion Date

May 15, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

AJA001

AJA001

OTHER

Placebo

Placebo

Trial Locations (1)

4006

Q-Pharm Pty Ltd, Brisbane

All Listed Sponsors

lead

AJNA Australia Pty Ltd

INDUSTRY